Search results for "HEART"

showing 10 items of 3201 documents

Can Ventricular Resynchronization Reduce Atrial Fibrillation Recurrences?

2003

In recent years a new pacing therapy has been proposed for patients affected by heart failure (HF) in order to reduce inter- [1,2], intra- [3,4], and atrioventricular [5] (AV) dyssynchrony. Cardiac resynchronization therapy (CRT) has the goal of correcting these hemodynamic disorders, thus improving left ventricular (LV) performance. The benefits of CRT have been evaluated in a series of clinical trials [6-10].

Atrial pacemedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCardiac resynchronization therapyHemodynamicsAtrial fibrillationmedicine.diseaseSick sinus syndromeClinical trialHeart failureInternal medicinecardiovascular systemmedicineCardiologycardiovascular diseasesbusiness
researchProduct

PACAP induces bradycardia in guinea-pig heart by stimulation of atrial cholinergic neurones

1996

Based on previous studies which indicated that pituitary adenylate cyclase activating peptide (PACAP) acts as a positive inotropic and chronotropic substance in different species via the cAMP signal transduction pathway, the objective of the present work was to investigate cAMP-regulated myocardial key proteins in response to PACAP in isolated ventricular cells of the guinea pig. Surprisingly, the two molecular forms of PACAP, PACAP(1-27) and PACAP(1-38), showed no effect on intracellular cAMP-levels, L-type Ca2+ channel current or phosphorylation of troponin inhibitor (TnI) and phospholamban (PLB). Additionally, inotropy of isolated guinea-pig ventricular strips was not affected by the neu…

AtropineMaleChronotropicendocrine systemmedicine.medical_specialtyGuinea PigsReceptors Pituitary Adenylate Cyclase-Activating PolypeptideStimulationIn Vitro TechniquesBiologyInternal medicineBradycardiaCyclic AMPmedicineAnimalsHeart AtriaReceptors Pituitary HormonePatch clampNeuronsPharmacologyNeurotransmitter AgentsMyocardiumCalcium-Binding ProteinsNeuropeptidesGeneral MedicineAcetylcholineRatsPhospholambanElectrophysiologyAtropinePituitary adenylate cyclase-activating peptideEndocrinologycardiovascular systemPituitary Adenylate Cyclase-Activating PolypeptideCholinergicFemalehormones hormone substitutes and hormone antagonistsAcetylcholineReceptors Pituitary Adenylate Cyclase-Activating Polypeptide Type ISignal Transductionmedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

Autoinhibition of nicotinic release of noradrenaline from postganglionic sympathetic nerves

1970

1. The effects of nicotine, DMPP (1,1-dimethylphenylpiperazine) and acetylcholine (plus atropine) on the isolated rabbit heart were investigated. Heart rate, amplitude of contraction, coronary flow and output of noradrenaline into the perfusate were recorded. Noradrenaline was estimated fluorimetrically. 2. All nicotinic drugs evoked a dose-dependent output of noradrenaline and increased the rate and the amplitude of contraction. Increases of heart rate in response to nicotine and DMPP and increases of amplitude of contraction in response to all nicotinic drugs were clearly related to the output of noradrenaline. 3. The dose-response curves of the noradrenaline output evoked by nicotine, DM…

AtropineMaleNicotinemedicine.medical_specialtySympathetic Nervous SystemContraction (grammar)Receptors DrugAdrenergicIn Vitro TechniquesPiperazinesNicotineNorepinephrinechemistry.chemical_compoundHeart RateInternal medicineHeart ratemedicineAnimalsFluorometryGanglia AutonomicNerve EndingsPharmacologyChemistryHeartGeneral MedicineAcetylcholineStimulation ChemicalPerfusionAtropineNicotinic agonistEndocrinologyFemaleHexamethoniumRabbitsAcetylcholineMuscle Contractionmedicine.drugNaunyn-Schmiedebergs Archiv f�r Pharmakologie
researchProduct

Safety and feasibility of atropine added in patients with sub-maximal heart rate during exercise myocardial perfusion SPECT.

2006

Failure to reach 80% of maximal predicted heart rate (HR) during exercise may render a myocardial perfusion single photon emission computed tomography (SPECT) study non-diagnostic for ischemia detection. We sought to investigate the injection of atropine in patients who fail to achieve 80% of age-predicted HR during exercise performed for myocardial perfusion SPECT (MPS), defining its safety and efficacy to raise HR to adequate levels as well as its effect on MPS interpretation.Between January 2002 and December 2004, we studied 3,150 consecutive patients (2,253 men and 897 women, mean age 55 +/- 6 years) who were referred to a single office-based nuclear cardiology laboratory for MPS using …

AtropineMalemedicine.medical_specialtyIschemiaMyocardial IschemiaBlood PressureSingle-photon emission computed tomographySeverity of Illness IndexMetabolic equivalentCholinergic AntagonistsOrganophosphorus CompoundsHeart RateInternal medicineSpect imagingCoronary CirculationHeart rateMedicineHumansRadiology Nuclear Medicine and imagingTomography Emission-Computed Single-Photonexercise testingmedicine.diagnostic_testmaximal predicted heart ratebusiness.industrymyocardial perfusion SPECTArrhythmias CardiacOrganotechnetium CompoundsMiddle Agedmedicine.diseaseAtropineRate pressure productResearch DesignCardiologyExercise TestFeasibility StudiesFemaleRadiopharmaceuticalsCardiology and Cardiovascular MedicinebusinessPerfusionmedicine.drugThe international journal of cardiovascular imaging
researchProduct

Spontaneous Cardiomyocyte Differentiation From Adipose Tissue Stroma Cells

2004

Cardiomyocyte regeneration is limited in adult life. Thus, the identification of a putative source of cardiomyocyte progenitors is of great interest to provide a usable model in vitro and new perspective in regenerative therapy. As adipose tissues were recently demonstrated to contain pluripotent stem cells, the emergence of cardiomyocyte phenotype from adipose-derived cells was investigated. We demonstrated that rare beating cells with cardiomyocyte features could be identified after culture of adipose stroma cells without addition of 5-azacytidine. The cardiomyocyte phenotype was first identified by morphological observation, confirmed with expression of specific cardiac markers, immunocy…

AtropineMalemedicine.medical_specialtyStromal cellPhysiologyCellular differentiationHeart VentriclesCholinergic AgentsAdipose tissueAdipose tissueCardiomyocytes ; Adipose tissue ; Differentiation ; Stem cells ; Cell therapyStem cellsBiologyCell therapyCell therapyMiceAdrenergic Agents:CIENCIAS MÉDICAS ::Medicina interna [UNESCO]Internal medicinemedicineAnimalsMyocytes CardiacHeart AtriaProgenitor cellInduced pluripotent stem cellCells CulturedUNESCO::CIENCIAS MÉDICAS ::Medicina internaCardiomyocytesRegeneration (biology)Multipotent Stem CellsIsoproterenolCell Differentiation:CIENCIAS MÉDICAS [UNESCO]Myocardial ContractionPropranololCell biologyClone CellsMice Inbred C57BLEndocrinologyPhenotypeAdipose TissueDifferentiationUNESCO::CIENCIAS MÉDICASRNACarbacholStem cellStromal CellsCardiology and Cardiovascular MedicineMyoblasts Cardiac
researchProduct

Effects of several muscarinic agonists on cardiac performance and the release of noradrenaline from sympathetic nerves of the perfused rabbit heart

1972

Summary 1 The effects of several muscarinic agonists on atrial tension development, ventricular rate and noradrenaline release from terminal sympathetic fibres evoked by electrical nerve stimulation (SNS) and 1,1-dimethyl-4-phenylpiperazinium (DMPP) were measured in isolated perfused rabbit hearts. 2 Hexamethonium, in a concentration which almost abolished the release of noradrenaline by DMPP, had no effect on the release produced by SNS, confirming that the stimulation was postganglionic. 3 The order of potency for inhibition of atrial tension development was N-methyl-1,2,5,6, tetrahydro-nicotinic acid prop-2-yne ester (MH-1)>oxotremorine > acetylcholine > methacholine > carbachol > furtre…

AtropineMalemedicine.medical_specialtySympathetic Nervous SystemCarbacholAutopharmacologyHexamethonium CompoundsIn Vitro TechniquesPharmacologyNorepinephrinechemistry.chemical_compoundHeart RateInternal medicineMuscarinic acetylcholine receptormedicineOxotremorineAnimalsMethacholine CompoundsPharmacologyChemistryOxotremorinePilocarpineHeartAcetylcholineElectric StimulationPerfusionQuaternary Ammonium CompoundsAtropineEndocrinologyParasympathomimeticsPilocarpineCarbacholFemaleMethacholineHexamethoniumCarbamatesRabbitsDimethylphenylpiperazinium IodideAcetylcholinemedicine.drugBritish Journal of Pharmacology
researchProduct

Storage and release of false transmitters after infusion of (+)- and (?)-?-methyldopamine

1971

Rabbits were given an infusion of 10 mg/kg (−)- or 30 mg/kg (+)-α-methyldopamine and killed after 135 min. The noradrenaline content of the heart was decreased to 26±5 and 34±2%, respectively, of the control value. After infusion of the (+)-isomer the missing noradrenaline was replaced by (−)-α-methylnoradrenaline. Electrical stimulation of the sympathetic nerves or infusion of acetylcholine plus atropine caused an output of noradrenaline and (−)-α-methylnoradrenaline from the isolated heart. The two amines were released in the same proportion as they were stored in the heart and the total output of both amines equalled the output of noradrenaline from control hearts. Nerve stimulation caus…

AtropineMalemedicine.medical_specialtySympathetic Nervous SystemDopamineMetaboliteAdrenergicBlood PressureStimulationSynaptic TransmissionMethyldopamineMethylaminesNorepinephrinechemistry.chemical_compoundIsomerismInternal medicinemedicineAnimalsPharmacologyCardiac cycleMyocardiumSignificant differenceHeartGeneral MedicineAcetylcholineElectric StimulationAtropineEndocrinologychemistryFemaleRabbitsAcetylcholinemedicine.drugNaunyn-Schmiedebergs Archiv f�r Pharmakologie
researchProduct

A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation

1969

1. The noradrenaline output from isolated rabbit hearts perfused with Tyrode solution was estimated fluorimetrically. The postganglionic sympathetic nerves of the heart were stimulated (10 shocks/sec; 1 msec) for three 1 min periods with intervals of 10 min. 2. The noradrenaline output evoked by 3 consecutive stimulation periods decreased exponentially. 3. Acetylcholine (10−9–10−6 g/ml) administered continuously one min before to one min after the second stimulation caused a dose-dependent reduction of the noradrenaline output evoked by the second stimulation to as low as 19% of the normal value. Acetylcholine in the concentrations applied did not cause a noradrenaline output by itself. 4. …

AtropineMalemedicine.medical_specialtySympathetic Nervous SystemTyramineStimulationHexamethonium CompoundsIn Vitro TechniquesPiperazinesNorepinephrinechemistry.chemical_compoundInternal medicineMuscarinic acetylcholine receptormedicineAnimalsMethacholine CompoundsFluorometryReceptors CholinergicPharmacologyHeartAdrenergic nervous systemGeneral MedicineCoronary VesselsAcetylcholineElectric StimulationReceptors AdrenergicPerfusionQuaternary Ammonium CompoundsAtropineEndocrinologyParasympathomimeticschemistryDepression ChemicalAutonomic Fibers PostganglionicCholinergicFemaleHexamethoniumMethacholineRabbitsAcetylcholinemedicine.drugNaunyn-Schmiedebergs Archiv f�r Pharmakologie
researchProduct

Cholinesterase activity and exposure time to acetylcholine as factors influencing the muscarinic inhibition of [3H]-noradrenaline overflow from guine…

1985

Guinea-pig isolated atria were incubated and loaded with [3H]-noradrenaline. The release of 3H and of [3H]-noradrenaline was induced by field stimulation (6-9 trains of 150 pulses at 5 Hz). The stimulation-evoked overflows of 3H and of [3H]-noradrenaline were determined. In the absence of an inhibitor of acetylcholinesterase, acetylcholine (12 min preincubation before nerve stimulation, up to 10 microM) failed to inhibit the evoked [3H]-noradrenaline overflow. In the presence of atropine, an increase by acetylcholine of evoked release was observed in the same atria. In contrast, the selective muscarinic agonist methacholine significantly decreased the evoked overflow. The inhibition was ant…

AtropinePhysostigminemedicine.medical_specialtyTime FactorsPhysostigmineGuinea PigsHexamethonium CompoundsIn Vitro TechniquesHexamethoniumMuscarinic agonistNorepinephrinechemistry.chemical_compoundCocaineInternal medicineMuscarinic acetylcholine receptormedicineAnimalsMethacholine CompoundsDrug InteractionsHeart AtriaPhentolamineMethacholine ChlorideCholinesterasePharmacologybiologyHeartPropranololReceptors MuscarinicAcetylcholineAtropineEndocrinologychemistryAcetylcholinesterasebiology.proteinMethacholineHexamethoniumCorticosteroneAcetylcholineResearch Articlemedicine.drugBritish Journal of Pharmacology
researchProduct

Supernormal conduction in the right bundle branch: lack of influence of autonomic blockade.

1984

A programmed atrial stimulation at a driving rate of 100/min was performed in a 47-year-old woman with left bundle branch block. Supernormal conduction lasting 40 ms was revealed within the right bundle branch. After autonomic blockade (0.2 mg propranolol/kg body weight and 0.04 mg atropine/kg body weight) the position and duration of the supernormal conduction did not change. This suggests that the autonomic nervous system has no influence on the supernormal phase of conduction in the human intraventricular conduction system.

Atropinemedicine.medical_specialtyBundle of HisSupernormal conductionBundle-Branch BlockPropranololHeart Conduction SystemInternal medicineDrug DiscoveryAutonomic blockademedicineHumansRight bundle branchGenetics (clinical)Bundle branch blockbusiness.industryLeft bundle branch blockGeneral MedicineMiddle Agedmedicine.diseasePropranololAutonomic nervous systemAtropineAnesthesiaCardiologyMolecular MedicineFemalebusinessmedicine.drugKlinische Wochenschrift
researchProduct